| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $303K | — | — |
| Cost of Revenue | $48 | — | -100.0% |
| Gross Profit | $303K | — | +331.1% |
| R&D Expense | $374K | -44.6% | -89.2% |
| SG&A Expense | $2.6M | -66.2% | -30.4% |
| Operating Income | $4.4M | +153.0% | +160.4% |
| Interest Expense | $295K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.2M | +9.2% | +14.4% |
| Current Assets | $9.1M | -3.2% | -22.3% |
| Total Assets | $82.8M | +48.7% | +263.2% |
| Current Liabilities | $4.0M | -60.8% | -74.4% |
| Total Liabilities | $12.0M | -34.2% | -36.9% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.7M | — | — |
| Capital Expenditures | $161K | — | — |
| Investing Cash Flow | -$65.6M | — | — |
| Financing Cash Flow | $82.4M | — | — |
| Free Cash Flow | -$10.9M | — | — |
| — |
| Net Income | $6.6M | +176.2% | +184.0% |
| EPS (Basic) | $0.26 | +110.4% | +336.4% |
| EPS (Diluted) | $0.05 | +102.0% | +145.5% |
| $70.8M |
| +89.4% |
| +1802.4% |